Elaxim 40 Injection is a prescription medication that contains Enoxaparin Sodium, a low molecular weight heparin used primarily for the prevention and treatment of thromboembolic disorders. With a strength of 40 mg per 0.4 ml, this injectable solution is ideal for the prophylaxis of deep vein thrombosis (DVT), treatment of acute DVT, and treatment of pulmonary embolism (PE). Additionally, Elaxim 40 Injection is effective in preventing venous thromboembolism in surgical patients, making it a vital component of patient care in both hospital and surgical settings. Elaxim 40 is administered subcutaneously, allowing for easy and effective application. The dosage and duration of treatment are tailored to the individual patient's conditions and needs, which ensures optimal therapeutic outcomes. Proper storage of Elaxim 40 involves keeping it below 25°C and protected from light, preserving its efficacy for the duration of treatment. Patients and healthcare providers should be aware of potential side effects, including bleeding, injection site reactions like pain and bruising, and thrombocytopenia. Close monitoring of platelet counts is recommended, especially in patients with renal impairment, as caution is advised in this group. Importantly, Elaxim 40 is intended for subcutaneous administration only and should not be used intramuscularly. Always consult a healthcare professional for guidance before use.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Enoxaparin Sodium (40 mg) |
| Formulation | Injectable Solution |
| Indications | Prophylaxis and treatment of DVT and PE |
| Dosage Administration | Subcutaneously |
| Storage Requirements | Below 25°C, protect from light |
| Precautions | Caution in renal impairment; monitor platelet counts |
| Side Effects | Bleeding, injection site reactions, thrombocytopenia |
| Prescription Status | Prescription-only medication |
| Attributes | Description |
|---|---|
| Drug Strength | 40 mg/0.4 ml |
| Manufacturer | [Include manufacturer's name if needed] |
| Administration Route | Subcutaneous |
| Storage Temperature | Below 25°C |
| Injection Restrictions | Not for intramuscular use |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Elaxim 40 Injection is indicated for the prophylaxis of deep vein thrombosis (DVT), treatment of acute DVT, treatment of pulmonary embolism (PE), and prophylaxis of venous thromboembolism in surgical patients.
Elaxim 40 Injection should be stored at a temperature below 25°C and protected from light to maintain its efficacy.
No, Elaxim 40 Injection is intended for subcutaneous administration only and should not be used intramuscularly.
Precautions include using Elaxim 40 with caution in patients with renal impairment and regularly monitoring platelet counts.
Common side effects include bleeding, injection site reactions such as pain or bruising, and thrombocytopenia.
Country Of Origin: India
Product Name: Elaxim 40 Injection
Active Ingredient: Enoxaparin Sodium (40 mg)
Form: Injectable Solution
Strength: 40 mg/0.4 ml
Indications:
Prophylaxis of deep vein thrombosis (DVT)
Treatment of acute deep vein thrombosis (DVT)
Treatment of pulmonary embolism (PE)
Prophylaxis of venous thromboembolism in surgical patients
Dosage and Administration:
Administered subcutaneously
Dosage and duration depend on the condition being treated and patient-specific factors
Storage:
Store at a temperature below 25°C
Protect from light
Precautions:
Use with caution in patients with renal impairment
Regular monitoring of platelet counts recommended
Not for intramuscular use
Side Effects:
Bleeding
Injection site reactions (pain, bruising)
Thrombocytopenia
Manufacturer: [Include manufacturer's name if needed]
Note: This is a prescription-only medication. Always consult a healthcare professional before use.
